| Product Name | Laduviglusib monohydrochloride | CHIR-99021 Monohydrochloride | T99021 Monohydrochloride |
|---|---|
| CAS | 1797989-42-4 |
| Formula | C22H18Cl2N8·HCl |
| MW | 501.80 |
| Appearance | White to yellow powder |
| Storage condition | 4°C, sealed storage, away from moisture |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
|---|---|---|---|---|---|
|
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible. |
|||||
| Product Name | Laduviglusib monohydrochloride | CHIR-99021 Monohydrochloride | T99021 Monohydrochloride |
|---|---|
| CAS | 1797989-42-4 |
| Formula | C22H18Cl2N8·HCl |
| MW | 501.80 |
| Appearance | White to yellow powder |
| Storage condition | 4°C, sealed storage, away from moisture |
Laduviglusib (CHIR-99021) monohydrochloride is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib monohydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib monohydrochloride is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib monohydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib monohydrochloride induces autophagy.